Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists.
Daperno M, Comberlato M, Bossa F, Armuzzi A, Biancone L, Bonanomi AG, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Grassano L, Pagana G, D'Incà R, Orlando A, Rizzello F; IGIBDEndo Group. Daperno M, et al. Among authors: cassinotti a. J Crohns Colitis. 2017 May 1;11(5):556-561. doi: 10.1093/ecco-jcc/jjw181. J Crohns Colitis. 2017. PMID: 28453758
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
Orlando A, Colombo E, Kohn A, Biancone L, Rizzello F, Viscido A, Sostegni R, Benazzato L, Castiglione F, Papi C, Meucci G, Riegler G, Mocciaro F, Cassinotti A, Cosintino R, Geremia A, Morselli C, Angelucci E, Lavagna A, Rispo A, Bossa F, Scimeca D, Cottone M; Italian Multicentric Study Group on Infliximab. Orlando A, et al. Among authors: cassinotti a. Dig Liver Dis. 2005 Aug;37(8):577-83. doi: 10.1016/j.dld.2005.01.019. Dig Liver Dis. 2005. PMID: 15886081 Clinical Trial.
Internet use among inflammatory bowel disease patients: an Italian multicenter survey.
Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, Astegiano M, Sociale O, Cesarini M, Renna S, Cassinotti A, Marzo M, Quaglia A, Sergi MD, Simondi D, Vernia P, Malesci A, Danese S. Angelucci E, et al. Among authors: cassinotti a. Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1036-41. doi: 10.1097/MEG.0b013e328321b112. Eur J Gastroenterol Hepatol. 2009. PMID: 19543105
CARD15 gene variants and risk of reoperation in Crohn's disease patients.
Maconi G, Colombo E, Sampietro GM, Lamboglia F, D'Incà R, Daperno M, Cassinotti A, Sturniolo GC, Ardizzone S, Duca P, Porro GB, Annese V. Maconi G, et al. Among authors: cassinotti a. Am J Gastroenterol. 2009 Oct;104(10):2483-91. doi: 10.1038/ajg.2009.413. Epub 2009 Jul 28. Am J Gastroenterol. 2009. PMID: 19638967
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
Cassinotti A, Keshav S, Ardizzone S, Mortensen N, Sampietro G, Fociani P, Duca P, George B, Lazzaroni M, Manes G, Warren B, Foschi D, Vago G, Porro GB, Travis S. Cassinotti A, et al. J Crohns Colitis. 2009 Dec;3(4):291-301. doi: 10.1016/j.crohns.2009.08.002. Epub 2009 Sep 17. J Crohns Colitis. 2009. PMID: 21172290 Free article.
Vitamin D and inflammatory bowel disease.
Ardizzone S, Cassinotti A, Bevilacqua M, Clerici M, Porro GB. Ardizzone S, et al. Among authors: cassinotti a. Vitam Horm. 2011;86:367-77. doi: 10.1016/B978-0-12-386960-9.00016-2. Vitam Horm. 2011. PMID: 21419280 Review.
Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).
Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG, Cassinotti A, Cosintino R, Lombardi G, Mangiarotti R, Papa A, Pica R, Rizzello F, D'Incà R, Orlando A. Daperno M, et al. Among authors: cassinotti a. Dig Liver Dis. 2014 Nov;46(11):969-73. doi: 10.1016/j.dld.2014.07.010. Epub 2014 Aug 19. Dig Liver Dis. 2014. PMID: 25154049
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'Incà R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Biancone L, et al. Dig Liver Dis. 2017 Apr;49(4):338-358. doi: 10.1016/j.dld.2017.01.141. Epub 2017 Jan 17. Dig Liver Dis. 2017. PMID: 28161290
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.
Fiorino G, Sturniolo GC, Bossa F, Cassinotti A, di Sabatino A, Giuffrida P, Danese S. Fiorino G, et al. Among authors: cassinotti a. Cells. 2019 May 30;8(6):523. doi: 10.3390/cells8060523. Cells. 2019. PMID: 31151306 Free PMC article. Clinical Trial.
54 results